Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133


Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116).

Marcellin F, Boyer S, Protopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S, Abega SC, Abé C, Moatti JP, Spire B, Carrieri MP; EVAL Study Group.

Trop Med Int Health. 2008 Dec;13(12):1470-8. doi: 10.1111/j.1365-3156.2008.02170.x. Epub 2008 Nov 5.


Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors.

Boyer S, Clerc I, Bonono CR, Marcellin F, Bilé PC, Ventelou B.

Soc Sci Med. 2011 Apr;72(8):1383-92. doi: 10.1016/j.socscimed.2011.02.030. Epub 2011 Mar 8.


Psychosocial correlates of inconsistent condom use among HIV-infected patients enrolled in a structured ART interruptions trial in Côte d'Ivoire: results from the TRIVACAN trial (ANRS 1269).

Protopopescu C, Marcellin F, Préau M, Gabillard D, Moh R, Minga A, Anzian A, Carrieri MP, Danel C, Spire B.

Trop Med Int Health. 2010 Jun;15(6):706-12. doi: 10.1111/j.1365-3156.2010.02524.x. Epub 2010 Mar 29.


Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).

Marcellin F, Protopopescu C, Abé C, Boyer S, Blanche J, Ongolo-Zogo P, Koulla-Shiro S, Moatti JP, Carrieri MP, Spire B; EVAL Study Group.

AIDS Care. 2010 Apr;22(4):441-51. doi: 10.1080/09540120903202913.


Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey).

Dia A, Marcellin F, Bonono RC, Boyer S, Bouhnik AD, Protopopescu C, Koulla-Shiro S, Carrieri MP, Abé C, Spire B; EVAL Study Group.

Sex Transm Infect. 2010 Apr;86(2):148-54. doi: 10.1136/sti.2008.035147. Epub 2009 Oct 16.


Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon -- data from the STRATALL ANRS 12110/ESTHER trial.

Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti JP, Marcellin F, Laurent C, Spire B, Delaporte E, Carrieri MP; ANRS 12110/ESTHER Study Group.

AIDS Care. 2013;25(3):347-55.


Delayed first consultation after diagnosis of HIV infection in Cameroon.

Marcellin F, Abé C, Loubière S, Boyer S, Blanche J, Koulla-Shiro S, Ongolo-Zogo P, Moatti JP, Spire B, Carrieri MP; EVAL Study Group.

AIDS. 2009 May 15;23(8):1015-9. doi: 10.1097/QAD.0b013e32832a5996.


Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, Ngeth C, Ferradini L, Delfraissy JF, Laureillard D.

Antivir Ther. 2008;13(5):697-703.


Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national cross-sectional survey.

Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, Moatti JP.

Bull World Health Organ. 2009 Apr;87(4):279-87.


Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

Antivir Ther. 2009;14(3):339-47.


Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116).

Marcellin F, Bonono CR, Blanche J, Carrieri MP, Spire B, Koulla-Shiro S; EVAL Study Group.

AIDS. 2010 Jan;24 Suppl 1:S17-25. doi: 10.1097/01.aids.0000366079.83568.a2. Erratum in: AIDS. 2010 Jan 28;24(3):477.


[Assessment of factors associated with patients' comprehension of treatment at the start of antiretroviral therapy].

Braga Ceccato Md, Acurcio Fde A, Vallano A, Comini César C, Crosland Guimarães MD.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):7-13. doi: 10.1016/j.eimc.2008.05.003. Epub 2009 Jan 9. Spanish.


Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment.

Sharma M, Singh RR, Laishram P, Kumar B, Nanao H, Sharma C, Ahmed T.

Int J Drug Policy. 2007 Aug;18(4):319-25. Epub 2007 Jun 21.


HIV/AIDS patient's satisfactory and their expectations with pharmacy service at specialist antiretroviral therapy (ART) units.

Karunamoorthi K, Rajalakshmi M, Babu SM, Yohannes A.

Eur Rev Med Pharmacol Sci. 2009 Sep-Oct;13(5):331-9.


Food security status in households of people living with HIV/AIDS (PLWHA) in a Ugandan urban setting.

Bukusuba J, Kikafunda JK, Whitehead RG.

Br J Nutr. 2007 Jul;98(1):211-7. Epub 2007 Mar 23.


Individual and structural factors associated with HIV status disclosure to main partner in Cameroon: ANRS 12-116 EVAL survey, 2006-2007.

Suzan-Monti M, Blanche J, Bilé P, Koulla-Shiro S, Abu-Zaineh M, Marcellin F, Boyer S, Carrieri MP, Spire B.

J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S22-6. doi: 10.1097/QAI.0b013e31821fcfa8.


Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

Ahoua L, Guenther G, Pinoges L, Anguzu P, Chaix ML, Le Tiec C, Balkan S, Olson D, Olaro C, Pujades-Rodríguez M.

BMC Infect Dis. 2009 Jun 3;9:81. doi: 10.1186/1471-2334-9-81.


Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods.

Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, Carrieri P, Laurent C, Spire B; Stratall ANRS 12110/ESTHER Study Group.

J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S40-3. doi: 10.1097/QAI.0b013e318222b5c2.


Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.

Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, Koulla-Shiro S, Mpoudi-Ngole E, Peeters M, Delaporte E.

Clin Infect Dis. 2009 May 1;48(9):1318-22. doi: 10.1086/597779.


Supplemental Content

Support Center